Philip Morris files Form 144 for proposed award sales

Philip Morris International reports proposed sales of vested equity awards under a Form 144.

Rhea-AI Filing Summary

Philip Morris International reports proposed sales of vested equity awards under a Form 144. The notice lists multiple vested restricted and performance awards tied to grant dates of 02/15/2023 and 02/21/2024, with examples including 3,227 and 9,436 shares, and a broker listed as UBS Financial Services Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 for PM disclose?

The Form 144 discloses proposed sales of vested restricted and performance awards by an issuer-related holder. The notice lists grant dates 02/15/2023 and 02/21/2024, and shows a broker as UBS Financial Services Inc.

How many shares are shown as examples in the filing for PM?

The filing includes per-award quantities as examples, including 3,227 shares and 9,436 shares tied to vested awards. Additional award quantities of 14,406 and 6,731 are also listed in the excerpt.

Who is the broker listed on the PM Form 144?

The broker identified in the excerpt is UBS Financial Services Inc, with an address at 1000 Harbor Blvd, 3rd Floor, Weehawken, NJ. The filing pairs that broker with the listed award sale entries.

Are the securities being sold described by grant type in the PM filing?

Yes. The entries specify award types as Vested Restricted Award and Vested Performance Award, each tied to specific grant dates and listed share quantities in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/19/2026 - 03:10 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001810730
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Philip Morris Int
SEC File Number	001-33708
Address of Issuer	677 Washington Blvd Suite 1100 Stamford CONNECTICUT 06901
Phone	2039052410
Name of Person for Whose Account the Securities are To Be Sold	EMMANUEL BABEAU
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	33800	6138080	1556679579	02/19/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/15/2023	Vested Restricted Award	Philip Morris Int			3227	02/19/2026	Wire
Common Stock	02/15/2023	Vested Performance Award	Philip Morris Int			9436	02/19/2026	Wire
Common Stock	02/21/2024	Vested Restricted Award	Philip Morris Int			14406	02/19/2026	Wire
Common Stock	02/21/2024	Vested Performance Award	Philip Morris Int			6731	02/19/2026	Wire

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/19/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for EMMANUEL BABEAU
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)